TITLE

Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: Clinical Management Issues

AUTHOR(S)
Mayer, Kenneth H.; Poles, Michael A.; Dieterich, Douglas T.
PUB. DATE
July 2000
SOURCE
Clinical Infectious Diseases;7/1/2000, Vol. 31 Issue 1, p154
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Studies clinical management issues concerning hepatitis C virus (HCV)/HIV virus coinfection. Interrelationships between highly active antiretroviral therapy and HCV infection; Increase in the incidence of HCV infection among HIV-infected patients; Approaches to treatment of HCV infection in HIV-infected patients.
ACCESSION #
5253299

 

Related Articles

  • Benefits of Curing Hepatitis C Infection. Marinho, Rui T.; Vitor, Sofia; Velosa, José // Journal of Gastrointestinal & Liver Diseases;Mar2014, Vol. 23 Issue 1, p85 

    The hepatitis C virus (HCV) infection is one of the most important chronic viral infections worldwide and affects 3% of the world population, approximately 170-200 million people. The consequences of chronic infection are liver cirrhosis and hepatocellular carcinoma, which develop in 20-30% of...

  • Guidelines for treating HCV-HIV patients undergo update. LoBuono, Charlotte // Drug Topics;3/22/2004, Vol. 148 Issue 6, pHSE15 

    Reports on the HCV-HIV International Panel's issuance of revised guidelines for treating patients with hepatitis C and HIV infections. Treatment recommendations; Results of co-infection trials; Drug dosage and administration.

  • Challenges in the Management of HIV and Hepatitis C Virus Co-infection. Lee, Winston; Dieterich, Douglas // Drugs;2004, Vol. 64 Issue 7, p693 

    Hepatitis C virus (HCV) has become a significant contributor to morbidity and mortality to those infected with HIV since the introduction of highly active antiretroviral therapy (HAART). The presence of HIV clearly has a negative effect on the natural history of HCV, although there is some...

  • Influence of Coinfection with Hepatitis C Virus on Morbidity and Mortality Due to Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy. Tedaldi, Ellen M.; Baker, Rose K.; Moorman, Anne C.; Alzola, Carlos F.; Furhrer, Jack; McCabe, Robert E.; Wood, Kathleen C.; Holmberg, Scott D. // Clinical Infectious Diseases;2/1/2003, Vol. 36 Issue 3, p363 

    To ascertain the impact of hepatitis C virus (HCV) infection on human immunodeficiency virus (HIV) disease progression and associated death in the era of highly active antiretroviral therapy (HAART), we examined mortality rates, the presence of other diseases, and antiretroviral use in an...

  • First Things First: Balancing Hepatitis C and Human Immunodeficiency Virus. Graham, Camilla S.; Koziel, Margaret James // Clinical Infectious Diseases;2/1/2003, Vol. 36 Issue 3, p368 

    Editorial. Comments on a study by Tedaldi and colleagues, about the coinfection of HIV and hepatitis C virus. Influence of coinfection on morbidity and mortality; Balancing the risks and benefits of treating each of these viral infections; Impact of the availability of highly active...

  • The function and evolution of the restriction factor viperin in primates was not driven by lentiviruses. Lim, Efrem S.; Wu, Lily I.; Malik, Harmit S.; Emerman, Michael // Retrovirology;2012, Vol. 9 Issue 1, p55 

    Background: Viperin, also known as RSAD2, is an interferon-inducible protein that potently restricts a broad range of different viruses such as influenza, hepatitis C virus, human cytomegalovirus and West Nile virus. Viperin is thought to affect virus budding by modification of the lipid...

  • Atazanavir.  // Reactions Weekly;12/1/2007, Issue 1180, p5 

    The article presents a medical case of a 61-year-old HIV-positive man who developed nephropathy after atazanair was added to his antiretroviral regimen. The patient had a 10- and 20-year history of hepatitis C virus and HIV infection, respectively. Saquinavir was substituted for atazanair,...

  • Waking up the immune system. Harrison, Charlotte // Nature Reviews Drug Discovery;Dec2006, Vol. 5 Issue 12, p990 

    The article discusses the therapeutic potential of interleukin-10 in the development of immune resistance and in prevention of the spread of chronic viral infections such as HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV) in humans, and lymphocytic choriomenigitis virus (LCMV) in...

  • Hepatitis C Virus Infection: From Margin to Center in Rhode Island and Beyond. TAYLOR, LYNN E. // Rhode Island Medical Journal;Jul2014, Vol. 97 Issue 7, p15 

    The article focuses on epidemiology, prevention and treatment of hepatitis C virus infection (HCV) and mentions that July 28 each year is celebrated as the World Hepatitis Day in honor of Nobel Laureate Baruch Samuel Blumberg's birthday. Topics discussed include HCV treatment guidelines issued...

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics